Literature DB >> 18586004

Diameter of tumor blood vessels is a good parameter to estimate HIF-1-active regions in solid tumors.

Hiroshi Harada1, Xuejun Xie, Satoshi Itasaka, Lihua Zeng, Yuxi Zhu, Akiyo Morinibu, Kazumi Shinomiya, Masahiro Hiraoka.   

Abstract

As the transcriptional activity of hypoxia-inducible factor 1 (HIF-1) is associated with resistance of tumor cells to current antitumor therapies, the spatiotemporal dynamics of HIF-1-active regions has been of great interest as a therapeutic target. In the present study, we established a unique cancer cell line, which changes color HIF-1-dependently, and monitored it during tumor progression. In imaging experiments, HIF-1-active cells appeared over the tumor xenograft, but dramatically decreased in number as blood vessels developed around the tumor. The remaining HIF-1-active cells at the center of the xenograft also disappeared after neovascularization. Thereafter, tumor growth was accelerated and HIF-1-active cells reappeared in different regions. The distance between HIF-1-active cells and the nearest vessels correlated to the diameter of the vessel (r=0.801). These results provide a basic knowledge of how to estimate the spatiotemporal dynamics of HIF-1-active cells using information about the image-guided architecture of tumor blood vessels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586004     DOI: 10.1016/j.bbrc.2008.06.062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha.

Authors:  Masashi Ueda; Takashi Kudo; Yuji Kuge; Takahiro Mukai; Shotaro Tanaka; Hiroaki Konishi; Azusa Miyano; Masahiro Ono; Shinae Kizaka-Kondoh; Masahiro Hiraoka; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-29       Impact factor: 9.236

2.  Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast.

Authors:  Rachel Morrison; James Thompson; Luke Bird; Mark A Hill; Helen Townley
Journal:  J Mater Sci Mater Med       Date:  2015-07-30       Impact factor: 3.896

3.  Mathematical and computational models of drug transport in tumours.

Authors:  C M Groh; M E Hubbard; P F Jones; P M Loadman; N Periasamy; B D Sleeman; S W Smye; C J Twelves; R M Phillips
Journal:  J R Soc Interface       Date:  2014-03-12       Impact factor: 4.118

4.  Drug delivery in a tumour cord model: a computational simulation.

Authors:  M E Hubbard; M Jove; P M Loadman; R M Phillips; C J Twelves; S W Smye
Journal:  R Soc Open Sci       Date:  2017-05-24       Impact factor: 2.963

5.  Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy.

Authors:  Chan Joo Yeom; Lihua Zeng; Yuxi Zhu; Masahiro Hiraoka; Hiroshi Harada
Journal:  Cancers (Basel)       Date:  2011-09-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.